Cellectis SA (CLLS)
2.57
-0.05
(-1.90%)
USD |
NASDAQ |
Apr 24, 14:57
Cellectis Free Cash Flow (Quarterly): -17.41M for Sept. 30, 2023
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2023 | -17.41M |
| June 30, 2023 | -19.31M |
| March 31, 2023 | -28.54M |
| December 31, 2022 | -1.478M |
| September 30, 2022 | -26.68M |
| June 30, 2022 | -24.48M |
| March 31, 2022 | -37.24M |
| December 31, 2021 | -20.50M |
| September 30, 2021 | -35.90M |
| June 30, 2021 | -17.58M |
| March 31, 2021 | -49.14M |
| December 31, 2020 | -50.04M |
| September 30, 2020 | -31.94M |
| June 30, 2020 | -36.20M |
| March 31, 2020 | -6.497M |
| December 31, 2019 | -5.531M |
| September 30, 2019 | -28.12M |
| June 30, 2019 | -24.24M |
| Date | Value |
|---|---|
| March 31, 2019 | -24.21M |
| December 31, 2018 | -23.07M |
| September 30, 2018 | -16.24M |
| June 30, 2018 | -13.10M |
| March 31, 2018 | -20.61M |
| December 31, 2017 | -10.04M |
| September 30, 2017 | -16.26M |
| June 30, 2017 | -11.87M |
| March 31, 2017 | -16.82M |
| December 31, 2016 | 0.532M |
| September 30, 2016 | -4.38M |
| June 30, 2016 | -12.89M |
| March 31, 2016 | -30.01M |
| December 31, 2015 | 27.69M |
| September 30, 2015 | -5.476M |
| June 30, 2015 | -18.73M |
| March 31, 2015 | -4.302M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-50.04M
Minimum
Dec 2020
-1.478M
Maximum
Dec 2022
-25.60M
Average
-25.58M
Median
Free Cash Flow (Quarterly) Benchmarks
| DBV Technologies SA | -14.04M |
| Biophytis SA | -- |
| Genfit SA | -- |
| Edap TMS SA | -5.566M |
| Biodexa Pharmaceuticals Plc | -- |